Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations

Ann Med. 2017 Sep;49(6):534-544. doi: 10.1080/07853890.2017.1320423. Epub 2017 May 3.

Abstract

Human immunodeficiency virus (HIV) infection remains a global pandemic. The primary driver of HIV incidence is sexual transmission between serodifferent individuals. Condoms, when used consistently and correctly, are effective at preventing sexually transmitted HIV infections and are considered an integral component of a comprehensive approach to HIV prevention. However, the demonstrated effectiveness of antiretroviral therapy (ART) to prevent HIV transmission, known as treatment as prevention and of pre-exposure prophylaxis, have raised an intriguing dilemma on the necessity and additive preventive benefit of condom use among individuals in serodifferent relationships utilizing these prevention strategies. Recent published evidence, although of limited follow-up duration, has shown no linked HIV transmissions with condomless sex among serodifferent couples where the infected partner was on ART and virologically suppressed. This paper will review the evidence surrounding HIV transmission risk among serodifferent couples with and without the use of condoms and will highlight factors that increase or attenuate this risk. It will also address the important benefits that condomless sex offers couples. This paper aims to provide a template for providers to have personalized discussions with their patients, particularly those with an HIV-positive sexual partner, around their individual risk of HIV transmission and the role of condom use.

Keywords: HIV transmission; condomless sex; serodifferent; serodiscordant.

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Condoms / statistics & numerical data
  • Female
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • HIV Seropositivity / transmission*
  • Humans
  • Male
  • Pre-Exposure Prophylaxis / methods*
  • Sexual Partners*
  • Unsafe Sex

Substances

  • Anti-HIV Agents